Ultragenyx Pharmaceutical (RARE) Minority Interest (2013 - 2026)
Ultragenyx Pharmaceutical (RARE) posted quarterly Minority Interest of $7.0 million for Q1 2026, little changed year-over-year from $7.0 million in Q1 2025, and little changed quarter-over-quarter from $7.0 million in Q4 2025.
Ultragenyx Pharmaceutical (RARE) Minority Interest (2013 - 2026) Analysis & Trends
Ultragenyx Pharmaceutical (RARE) has reported Minority Interest for 4 consecutive years, with $7.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Minority Interest changed 0.0% year-over-year to $7.0 million; the TTM figure through Mar 2026 stood at $7.0 million (changed 0.0% YoY), while the FY2025 annual figure was $7.0 million, changed 0.0% from the prior year.
- Minority Interest steadied at $7.0 million in Q1 2026 per RARE's latest filing, from $7.0 million in the prior quarter.
- Across five years, Minority Interest topped out at $7.0 million in Q3 2024 and bottomed at $7.0 million in Q3 2024.
- Historically, Minority Interest has averaged $7.0 million across 3 years, with a median of $7.0 million in 2024.
- On a YoY basis, Minority Interest climbed as much as 0.0% in 2025 and fell as far as 0.0% in 2025.
- Ultragenyx Pharmaceutical's Minority Interest stood at $7.0 million in 2024, then changed by 0.0% to $7.0 million in 2025, then changed by 0.0% to $7.0 million in 2026.
- Business Quant data shows RARE's Minority Interest at $7.0 million in Q1 2026, $7.0 million in Q4 2025, and $7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.61 Bn | 2.33 Bn | 180.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.00 Mn |
| Mar 31, 2026 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 7.00 Mn |
| Dec 31, 2024 | 7.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Dec 31, 2013 | 73.93 Mn |